Recommended Topic Related To:


"The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), with or without conjunctivitis (eye inflam"...


How Supplied


Treatment Of Nasal Symptoms Of Allergic Rhinitis

QNASL Nasal Aerosol is indicated for the treatment of the nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older.


Administer QNASL Nasal Aerosol by the intranasal route only. QNASL Nasal Aerosol must be primed prior to initial use by actuating four times. To do this, remove the protective dust cap from the device, hold the device upright between your thumb and forefinger (index finger) (the canister should be on top, pointing down), and spray 4 times into the air, away from your eyes and face. After the initial priming, the dose counter should read 120. If QNASL Nasal Aerosol is not used for 7 consecutive days it should be primed by spraying 2 times. See accompanying illustrated PATIENT INFORMATION and Instructions for Use leaflet for proper use of QNASL Nasal Aerosol.

Allergic Rhinitis

Adults and Adolescents (12 Years of Age and Older)

The recommended dose of QNASL Nasal Aerosol is 320 mcg per day administered as 2 nasal aerosol sprays in each nostril (80 mcg/aerosol spray) once daily (maximum total daily dose of 4 nasal aerosol sprays per day).


Dosage Forms And Strengths

QNASL Nasal Aerosol is a nonaqueous nasal spray solution. Each actuation of the aerosol delivers 80 mcg of beclomethasone dipropionate.

Storage And Handling

QNASL Nasal Aerosol is supplied as a pressurized aluminum canister inserted into a blue and white plastic nasal actuator with a built-in dose counter and white dust cap. Each canister contains 8.7 g of drug and excipients and provides 120 actuations (NDC 59310-210-12). Each actuation delivers 80 mcg of beclomethasone dipropionate from the nasal actuator and 100 mcg from the valve.

QNASL Nasal Aerosol has a built-in spray counter, which starts at 124 and counts down each time an aerosol spray is released. The correct amount of medication in each intranasal dose cannot be ensured after the counter reads 0; therefore, the device should be discarded when the counter reads 0.

Do not remove the QNASL Nasal Aerosol canister from the actuator. The QNASL Nasal Aerosol canister should only be used with the QNASL Nasal Aerosol actuator and the actuator should not be used with any other drug product.

Contents Under Pressure

Do not puncture. Do not store near heat or open flame. Do not expose to temperatures higher than 49°C (120°F) as this may cause bursting of the canister. Never throw the device into a fire or an incinerator.

Store at 25°C (77°F); excursions are permitted between 15° and 30°C (59° and 86°F).

Keep out of reach of children.

Manufactured for Teva Respiratory, LLC Horsham, PA 19044 By: 3M Drug Delivery Systems Northridge, CA 91324. Rev. 06/12

Last reviewed on RxList: 4/1/2014
This monograph has been modified to include the generic and brand name in many instances.

How Supplied

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Allergies & Asthma

Improve treatments & prevent attacks.